ITALY, January 20TH 2018 – Corion Biotech is pleased to announce that it has been granted an international patent in Europe concerning the treatment of epithelial tumors using a placental mesenchymal cells-derived biological.

Novel stem cell-based therapies play an important role in tumoral management even if their application in clinical practice is still a challenge. Corion Biotech, by its “cell therapy without cells” approach, developed a placental mesenchymal stem cells-derived biological that exerts a surprising inhibitory effect on tumoral proliferation and angiogenesis both in primary and metastatic advanced stage epithelial tumours (e.g. ovarian and breast cancers).